In this episode, Dr Shoona Vincent, Vice President of Clinical Science at MAC Clinical Research, shares expert insights into the evolving field of psychedelic therapies. Drawing on MAC’s extensive experience in conducting controlled, regulatory-grade trials in this space, the episode explores the current challenges, key considerations in trial design, and what’s next for psychedelic research.
With MAC’s scientific leadership and specialist infrastructure, this episode offers a focused look at the reality of bringing psychedelic therapies closer to market through robust clinical development.
